Nusinersen and risdiplam for treating spinal muscular atrophy
Agency for Care Effectiveness (ACE)
Record ID 32018014169
English
Details
Project Status:
Completed
Year Published:
2024
URL for published report:
https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/nusinersen-and-risdiplam-for-treating-spinal-muscular-atrophy
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Singapore
MeSH Terms
- Muscular Atrophy, Spinal
- Spinal Muscular Atrophies of Childhood
- Survival of Motor Neuron 1 Protein
- Azo Compounds
- Child
- Oligonucleotides
- Pyrimidines
- Neuromuscular Agents
Contact
Organisation Name:
Agency for Care Effectiveness (ACE)
Contact Address:
Ministry of Health, College of Medicine Building, 16 College Road, Singapore 169854
Contact Name:
ACE_HTA@moh.gov.sg
Contact Email:
ACE_HTA@moh.gov.sg
Copyright:
Agency for Care Effectiveness (ACE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.